|
SYRE Spyre Therapeutics Inc 1636282 |
| Balance Sheet |
|
Current Assets
|
608,474,000 |
|
Assets
|
608,484,000 |
|
Current Liabilities
|
54,060,000 |
|
Liabilities
|
90,680,000 |
|
Equity
|
517,804,000 |
|
Shares Out
|
50,920,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-157,410,000 |
|
Investing Cash Flow
|
-353,285,000 |
| Market Analysis |
Market Cap
|
1,476,534,180 |
|
Price
|
18.36 |
|
BVPS
|
10.17 |
|
PB
|
1.80 |
|
EPS
|
-15.42 |
|
PS
|
0.58 |
|
FCF
|
-510,695,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SYRE documents filed with the SEC.
SYRE Filings
Clear
